These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25520649)

  • 1. Delayed intratumoral hemorrhage after drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma.
    Shiozawa K; Watanabe M; Ikehara T; Ogino Y; Umakoshi T; Matsukiyo Y; Kogame M; Matsui T; Kikuchi Y; Igarashi Y; Sumino Y
    Case Rep Oncol; 2014 Sep; 7(3):739-45. PubMed ID: 25520649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.
    Shiozawa K; Watanabe M; Ikehara T; Yamamoto S; Matsui T; Saigusa Y; Igarashi Y; Maetani I
    World J Hepatol; 2018 Jan; 10(1):95-104. PubMed ID: 29399283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemobilia immediately after transcatheter arterial chemoembolization using drug-eluting beads for hepatocellular carcinoma with intrahepatic bile duct invasion.
    Nishi M; Saeki I; Yamasaki T; Maeda M; Hisanaga T; Iwamoto T; Matsumoto T; Hidaka I; Ishikawa T; Takami T; Sakaida I
    Hepatol Res; 2018 Mar; 48(4):329-332. PubMed ID: 29098752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Therapeutic Efficacy of Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound.
    Shiozawa K; Matsui T; Murakami T; Watanabe M; Maetani I
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33673221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of drug-eluting bead transarterial chemoembolization loaded with cisplatin on normal dogs.
    Nakasumi K; Yamamoto N; Takami T; Itoh H; Itamoto K; Horikirizono H; Iseri T; Nakaichi M; Nemoto Y; Sunahara H; Tani K
    J Vet Med Sci; 2022 Jan; 84(1):114-120. PubMed ID: 34866073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of initial tumor responses to transarterial bland embolization and drug-eluting beads-transarterial chemoembolization in the management of hepatocellular carcinoma: a propensity-score matching analysis.
    Guo J; Wang W; Zhang Y; Xu L; Kong J
    J Gastrointest Oncol; 2021 Aug; 12(4):1838-1850. PubMed ID: 34532132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.
    Baur J; Ritter CO; Germer CT; Klein I; Kickuth R; Steger U
    Hepat Med; 2016; 8():69-74. PubMed ID: 27382341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of resected hepatocellular carcinoma after drug-eluting bead transarterial chemoembolization].
    Ikeda A; Yasuhara Y; Hirata D; Teramura M; Nakamura T; Oiwa Y; Araki O; Azechi H; Nishitai R; Kokuryu H
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(6):983-92. PubMed ID: 27264430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
    Ludwig JM; Zhang D; Xing M; Kim HS
    Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
    BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Huang K; Zhou Q; Wang R; Cheng D; Ma Y
    J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20-40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm.
    Cho SM; Chu HH; Kim JW; Kim JH; Gwon DI
    Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33919658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
    Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
    Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
    [No Abstract]   [Full Text] [Related]  

  • 18. Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma.
    Galastri FL; Nasser F; Affonso BB; Valle LGM; Odísio BC; Motta-Leal Filho JM; Salvalaggio PR; Garcia RG; de Almeida MD; Baroni RH; Wolosker N
    World J Hepatol; 2020 Jan; 12(1):21-33. PubMed ID: 31984118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres
    Ma Y; Zhao C; Zhao H; Li H; Chen C; Xiang H; Zheng C; Ma C; Luo C; Qiu H; Yao Y; Hu H; Xiong B; Zhou J; Zhu H; Long Q
    Am J Transl Res; 2019; 11(12):7456-7470. PubMed ID: 31934293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
    Xing M; Webber G; Prajapati HJ; Chen Z; El-Rayes B; Spivey JR; Pillai AA; Kim HS
    J Gastroenterol Hepatol; 2015 Jul; 30(7):1167-74. PubMed ID: 25675849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.